RxDoctor Payments Data

Stephanie Montrose, DO

Family Medicine · Clarkston, MINPI 1083062681

Payments from drug & device makers

$3,154in general payments, 2019–2025

Across 215 payments — averaging $14.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$747
  • AbbVie$545
  • Pfizer$467
  • Merck$195
  • Amgen$142
  • Bayer$124
  • plus $935 from 31 others

What the payments were for

  • Food & beverage$3,154100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,154 in reported general payments places this provider in the 85th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$94,053
Medicare patients
187
Services billed
1,245

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin217$177,278
OzempicSemaglutide116$163,973
EliquisApixaban105$71,048
IngrezzaValbenazine Tosylate16$58,783
Trelegy ElliptaFluticasone/Umeclidin/Vilanter37$48,255
InvokanaCanagliflozin53$43,002
MounjaroTirzepatide26$32,578
TrulicityDulaglutide21$28,218
XareltoRivaroxaban18$17,337
FarxigaDapagliflozin Propanediol28$15,366
JanuviaSitagliptin Phosphate15$14,495
EntrestoSacubitril/Valsartan40$10,804
Lacosamide18$6,068
Midodrine Hcl57$5,880
Atorvastatin Calcium291$4,488

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$31$177,278217 claims
Novo NordiskOzempic$747$163,973116 claims
PfizerEliquis$467$71,048105 claims
Lilly USA, LLCMounjaro, Trulicity$96$60,79647 claims
Johnson & JohnsonInvokana, Xarelto$70$60,33971 claims
GSKTrelegy Ellipta, Arexvy, Shingrix$27$55,23563 claims
AstraZenecaFarxiga, Symbicort$43$19,39942 claims
MerckJanuvia$195$14,49515 claims
AbbVieArmour Thyroid$545$1,88726 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Clarkston

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →